Extracellular stability of nanoparticulate drug carriers
- PMID: 24214175
- PMCID: PMC4277600
- DOI: 10.1007/s12272-013-0286-0
Extracellular stability of nanoparticulate drug carriers
Abstract
Nanoparticulate (NP) drug carrier systems are attractive vehicles for selective drug delivery to solid tumors. Ideally, NPs should evade clearance by the reticuloendothelial system while maintaining the ability to interact with tumor cells and facilitate cellular uptake. Great effort has been made to fulfill these design criteria, yielding various types of functionalized NPs. Another important consideration in NP design is the physical and functional stability during circulation, which, if ignored, can significantly undermine the promise of intelligently designed NP drug carriers. This commentary reviews several NP examples with stability issues and their consequences, ending in a discussion of experimental methods for reliable prediction of NP stability.
Figures



References
-
- Burt HM, Zhang X, Toleikis P, Embree L, Hunter WL. Development of copolymers of poly(d, l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel. Colloids and Surfaces B. 1999;16:161–171.
-
- Chen H, Kim S, He W, Wang H, Low PS, Park K, Cheng J-X. Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo Förster resonance energy transfer imaging. Langmuir. 2008a;24:5213–5217. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous